<DOC>
	<DOCNO>NCT01407523</DOCNO>
	<brief_summary>To evaluate safety Levetiracetam IV 15-minute infusion administer every 12 hour adjunctive treatment subject Partial Onset Seizures switch equivalent Levetiracetam oral dose .</brief_summary>
	<brief_title>An Open Label Study L059 Intravenous ( IV ) Japanese Epilepsy Subjects With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subject male female age ≥ 16 year Subject Partial Onset Seizures classifiable accord 1981 International League Against Epilepsy ( ILAE ) classification Epileptic Seizures Subject weigh ≥ 40 kg Subject currently take Levetiracetam ( LEV ) adjunctive antiepileptic oral treatment 1 3 Antiepileptic Drugs ( AEDs ) Subject problem venous accessibility Subject participate another clinical/pharmacological study last 4 week prior Screening Visit Subject pregnant lactating Subject history suicide attempt ( ) present current depressive sign , current suicidal ideation , and/or behavior Subject clinically significant Electrocardiogram ( ECG ) abnormalities accord investigator</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Infusion</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Partial Onset Seizures</keyword>
</DOC>